Cidara Therapeutics
Price & Volume
Stats
See more52W Range | $10.14-$90.85 |
Market Cap | $2.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$108.7M |
Diluted EPS | -$7.63 |
News
See moreYahoo Finance • yesterday
Cidara Doses First Participants In Phase 3 ANCHOR Trial Of CD388 In High-Risk Flu Population
Yahoo Finance • 2 days ago
Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations
Yahoo Finance • 3 days ago
Cidara jumps after expedited late-stage trial plan for flu therapy
About
CEO | Dr. Jeffrey L. Stein Ph.D. |
Address | 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |
